We regret to state that Figure 1A was misrepresented in this article. Hence, we publish this erratum to replace it with the correct image. This correction does not alter any interpretations or conclusions of the study. We sincerely apologize for this oversight and any confusion this may have caused. The corrected images for Figure 1 are shown below.
Figure 1.
Low-expression of CXCL12 in breast cancer with worse prognosis. A. Western blot analysis demonstrated the CXCL12 expression in breast cancer tissues and matched distal normal tissues from four randomly selected breast cancer patients. B. Immunohistochemistry results of CXCL12 expression in paired breast cancer tissue samples. C. Kaplen-Meier survival curves for 52 patients with breast cancer, grouped according to CXCL12 expression.